Vaso Corporation CEO Outlines 2025 Priorities and Reflects on Year of Growth and Innovation in Annual Letter.

Vaso Corporation released a letter to shareholders and employees highlighting the company's growth and innovation throughout the year. The letter focuses on operational developments, product updates, financial performance, and thought-leadership initiatives. The company is looking forward to a promising 2025 with a focus on healthcare professional sales services, network and IT services, and proprietary medical products.

Vaso Corporation, a leading player in the healthcare equipment and information technology industries, recently released a letter to its shareholders and employees, highlighting the company's achievements and milestones throughout the past year [1]. The letter, filled with operational developments, product updates, financial performance, and thought-leadership initiatives, paints a picture of a company that is not only thriving but also innovating and looking forward to a promising future.

The company's success story began with its professional sales service segment, which experienced exceptional growth in 2022, driving the company's total revenue to $80.0 million, a 5.9% increase over the previous year [2]. This growth was compounded by an improvement in gross profit, resulting in an annual operating profit of $7.9 million, a 12.4% increase year-over-year.

Vaso's IT segment, operated through a wholly owned subsidiary, VasoTechnology, Inc., focuses on healthcare IT and managed network technology services. The company's professional sales service segment, operated through Vaso Diagnostics, Inc., specializes in the sale of healthcare capital equipment for GE HealthCare into the health provider middle market. Meanwhile, the Equipment segment, which operates through VasoMedical, Inc., designs, manufactures, sells, and services proprietary medical devices and software.

With a workforce of 300 employees, Vaso Corporation is committed to providing its employees with the necessary support to balance their personal and professional lives while navigating the uncertainties of the business world. The company's dedication to its employees is reflected in its financial performance, with a focus on operational efficiency and a commitment to delivering value to its shareholders.

Looking ahead to 2025, Vaso Corporation is focusing on healthcare professional sales services, network and IT services, and proprietary medical products. The company's commitment to innovation and growth is evident in its strategic focus on these areas, which are expected to drive further growth and success in the years to come.

In conclusion, Vaso Corporation's 2022 success story is a testament to the company's commitment to growth, innovation, and its employees. With a strong financial performance and a strategic focus on the healthcare professional sales services, network and IT services, and proprietary medical products, Vaso Corporation is well-positioned to continue its growth trajectory and deliver value to its shareholders in the years to come.

References:
[1] Vaso Corporation. (2023, March 29). Vaso Corporation Announces Financial Results for Fourth Quarter and Full Year of 2022. Retrieved from https://www.accesswire.com/746125/vaso-corporation-announces-financial-results-for-fourth-quarter-and-full-year-of-2022
[2] MarketScreener. (2024, November 14). Vaso Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024. Retrieved from https://www.marketscreener.com/quote/stock/VASO-CORPORATION-120787682/company/